A Rare Entity Pituitary FDG Uptake; What Should We Expect?
International Journal of Clinical Endocrinology and Metabolism · 2017
DOI: 10.17352/ijcem.000023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Endocrinology and Metabolism, 2017. Verfasst von ZP Koç und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely accepted modality in order to evaluate the cancer patients for staging, restaging and treatment response evaluation.
Zitieren
APA
Koç, Z., Kara, P., & Sezer, E. (2017). A Rare Entity Pituitary FDG Uptake; What Should We Expect?. International Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.17352/ijcem.000023
Vancouver
Koç Z, Kara P, Sezer E. A Rare Entity Pituitary FDG Uptake; What Should We Expect?. International Journal of Clinical Endocrinology and Metabolism. 2017. doi:10.17352/ijcem.000023
BibTeX
@article{Ko2017,
author = {Koç, ZP and Kara, PO and Sezer, E},
title = {A Rare Entity Pituitary FDG Uptake; What Should We Expect?},
journal = {International Journal of Clinical Endocrinology and Metabolism},
year = {2017},
doi = {10.17352/ijcem.000023}
}
EUVIMED